On this World TB Day 2026, get inspired by real TB survivors who beat drug-resistant TB. Discover India’s fastest global progress, the official “Yes! We Can End TB” theme, and practical tips to prevent and eliminate tuberculosis

New Delhi: On World Tuberculosis Day, people across the world come together around the powerful 2026 theme: “Yes! We can end TB!” – Led by countries, powered by people. This is not just a slogan—it is a strong message of hope supported by real progress, even though TB is still the deadliest infectious disease in the world.

While many reports only share basic facts, this story goes further. It highlights India’s major achievements, new tools reaching people at the ground level, and a real-life survivor story that shows recovery is possible.

The History Behind World TB Day

March 24 is observed because on this day in 1882, German scientist Robert Koch announced the discovery of Mycobacterium tuberculosis, the bacteria that causes TB. At that time, TB was responsible for the death of one in seven people in Europe and North America. His discovery became the base for today’s TB diagnosis and treatment. Now, 144 years later, the fight is still on—but with far more advanced tools than Koch could have imagined.

2026 Theme: A Message of Hope and Action

The World Health Organization (WHO) selected the theme “Yes! We can end TB!” to show that ending TB is possible. The main focus areas include:

• Strong leadership and investment by countries
• Fast use of new technologies and treatments
• Collaboration across different sectors
• Patient-focused care without stigma

WHO also highlights that every dollar spent on TB can bring up to USD 43 in health and economic benefits. With strong commitment, countries can protect progress and build better health systems.

Global TB Burden in 2024: Latest WHO Data

As per the WHO Global Tuberculosis Report 2025:

• 10.7 million people fell sick with TB worldwide
• 1.23 million people died (including 150,000 people with HIV)
• 83 million lives have been saved since 2000
• Eight countries account for two-thirds of TB cases: India (25%), Indonesia, Philippines, China, Pakistan, Nigeria, DR Congo, and Bangladesh

Since 2015, TB cases have reduced by only 12%, which is much lower than the 50% target. About 78% of patients received treatment, but 2.4 million people are still not diagnosed every year.

India’s Record Progress: Leading the Fight

India bears the highest burden but is setting the pace. TB incidence dropped 21% (nearly double the global decline), mortality fell significantly, and “missing cases” are now under 1 lakh. Treatment success rate stands at 90%. This progress comes from the National Tuberculosis Elimination Programme (NTEP), Ni-kshay Poshan Yojana (₹500–₹1,000 monthly nutrition support), Nikshay Portal, and over 2 lakh Ni-kshay Mitras.

This progress is due to the National Tuberculosis Elimination Programme (NTEP) and key initiatives such as:

• Ni-kshay Poshan Yojana: ₹500–₹1,000 monthly nutrition support through Direct Benefit Transfer; ₹4,406 crore given to 1.37 crore people since 2018
• Nikshay Portal: A digital system connecting public and private healthcare
• TB Mukt Bharat Abhiyan: Over 2 lakh volunteers (Ni-kshay Mitras) helping patients with food and emotional support

Five districts in India have already met End-TB targets, and many others are close.

Persistent Challenges: The Fight Is Not Over

Despite progress, challenges remain:

• India accounts for 32% of global drug-resistant TB (MDR/RR-TB) cases
• Undernutrition contributes to nearly 50% of TB cases in India
• Social stigma and lack of funding still affect treatment

Drug-resistant TB needs longer and tougher treatment, but success rates have improved to 87% in some programmes.

Game-Changing Innovations Bringing New Hope

WHO is promoting fast rollout of new tools, including:

• Quick diagnostic tests near patient locations
• Shorter, all-oral treatments like BPaL for drug-resistant TB
• New vaccines (like M72/AS01E) in advanced trial stages
• AI-based chest X-rays and digital tracking systems

These are not future ideas—they are already being used and expanded.

Inspiring Story: Bhakti Chavan’s Victory Over XDR-TB

A real-life example from Mumbai shows that TB can be cured.

Bhakti Chavan, a 24-year-old biotechnology student, was diagnosed with extremely drug-resistant TB (XDR-TB) in 2017 after an initial wrong diagnosis. Her treatment included new medicines like delamanid, daily injections, and multiple tablets for nearly two years.

She faced severe side effects like vomiting, nerve problems, and repeated hospital visits. With strong family support and help from Médecins Sans Frontières (MSF), she stayed strong.

Bhakti completed treatment in 2019 and is now fully cured. Her story shows that early diagnosis, access to new treatment, and strong support can lead to full recovery.

What You Can Do: Simple Prevention Tips

Watch for symptoms and get tested early (free at government centres):

• Cough lasting more than 2 weeks
• Fever, night sweats, weight loss
• Chest pain or coughing blood

Prevention tips:

• Complete the full treatment—do not stop midway
• Eat healthy and nutritious food
• Avoid crowded and poorly ventilated places
• Get tested if you were in contact with a TB patient
• Support patients or become a Ni-kshay Mitra

Call to Action: Test, Treat, and Talk

Governments need to invest more, and communities must support patients. Ending TB requires everyone’s effort—this is what “powered by people” truly means.

Yes! We Can End TB – The Way Forward

This World TB Day, India’s faster progress and new innovations show that ending TB is possible. With strong leadership, proper funding, and public support, a TB-free India—and world—can become a reality by 2030.

If you or someone you know has symptoms, visit your nearest Ayushman Arogya Mandir or call the TB helpline. Together, we can turn “Yes! We can” into “We did.”

Also Read on jabalpur today: “I’m Not Sure If He Came Inside Me” – A Clear, Practical Guide to take the Emergency Pill and How to Prevent Pregnancy After Unprotected Sex